In addition to peripheral insulin resistance, obesity impairs insulin sensitivity in the hypothalamus, where the central Resistin/TLR4 signaling axis has been implicated in promoting hypothalamic inflammation and systemic metabolic dysfunction. Here, INS is linked to obesity disorder.